Recruiting NA INTERVENTIONAL 1-arm NCT05532566

Quercus Ilex and Quercus Robur Allergen Extracts Standardisation

Quercus Ilex and Quercus Robur Allergen Extracts. Determination of the in Vivo Allergenic Potency in Histamine Equivalent Units (HEP).

Sponsor: Inmunotek S.L.

Conditions Allergic Reaction Allergic Skin Reaction Allergy Pollen

Interventions Allergenic extract

Updated 5 times since 2022 Last updated: Apr 30, 2025 Started: Jan 24, 2023 Primary completion: Nov 30, 2025 Completion: Nov 30, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05532566, this NA trial focuses on Allergic Reaction and Allergic Skin Reaction and remains actively recruiting participants. Sponsored by Inmunotek S.L., it has been updated 5 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Jun 2025 — Present [monthly]

Recruiting NA
Oct 2024 — Jun 2025 [monthly]

Recruiting NA

Status: Unknown → Recruiting
Sep 2024 — Oct 2024 [monthly]

Unknown NA

Status: Not Yet Recruiting → Unknown
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting NA
Sep 2022 — Jul 2024 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Inmunotek S.L.

Data source: Inmunotek S.L.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Madrid, Spain